Sponsor or institution

Clinical trials and research at Gentibio, INC.

• 2Clinical trials
• 4NIH research projects
• 1Country

All recruiting trials (2)

• GNTI-122 cell therapy for adults recently diagnosed with type 1 diabetes

  This test uses an experimental cell therapy made from your own blood, called GNTI-122, to try to preserve insulin production in adults who were recently diagnosed with type 1 diabetes.

  Recruiting at 9 sites Phase 1 GentiBio, Inc · Duarte, California and 9 other locations · NCT06919354

• HLA-DRB1*04:01 genetics in adults with type 1 diabetes

  This test will look for the HLA-DRB1*04:01 gene in adults diagnosed with type 1 diabetes within the past six months.

  Recruiting at 5 sites GentiBio, Inc · San Francisco, California and 4 other locations · NCT06860516

NIH-funded research (4)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Engineered Tissue Treg Therapy for ALS (ALS)

  A new, patient-focused therapy using engineered immune cells (Tregs) to reduce brain inflammation and slow ALS progression.

  NIH research Gentibio, INC. · Cambridge, United States · NIH-11405442

• GNTI-148: an off-the-shelf engineered regulatory T cell therapy for new-onset type 1 diabetes

  A new, ready-to-use cell therapy derived from donor cells aims to restore immune tolerance and protect insulin-producing cells in people newly diagnosed with type 1 diabetes.

  NIH research Gentibio, INC. · Cambridge, United States · NIH-11400166

• Engineered tissue regulatory T cells as a treatment for stroke

  A new off-the-shelf cell therapy using engineered regulatory T cells could help people who have an ischemic stroke recover by reducing inflammation and promoting tissue repair.

  NIH research Gentibio, INC. · Cambridge, United States · NIH-11396531

• Engineered gut-targeted regulatory T cells for inflammatory bowel disease

  A new allogeneic, gut-focused cell therapy using engineered regulatory T cells to help people with inflammatory bowel disease feel better and stay in remission.

  NIH research Gentibio, INC. · Cambridge, United States · NIH-11394173

Quick answers

How many clinical trials run by Gentibio, INC. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →